US 10363248
Salts of heterocyclic modulators of HIF activity for treatment of disease
granted A61KA61K31/4245A61K31/4439
Quick answer
US patent 10363248 (Salts of heterocyclic modulators of HIF activity for treatment of disease) held by The Board of Regents of the University of Texas System expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/4245, A61K31/4439, A61K31/454, A61K31/4545